Study of REGN1193 in Patients With Type 2 Diabetes Mellitus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of REGN1193 in patients with Type 2 Diabetes Mellitus.
Epistemonikos ID: 88e0f9a25cacad58033d9da5881658755f6acc5a
First added on: May 12, 2024